Does Mounjaro Help You Get Pregnant — and When Should You Stop?

How weight loss on Mounjaro can affect fertility

Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for weight management, it works partly by slowing gastric emptying and reducing appetite, which leads to meaningful, sustained weight reduction for many people. That weight loss is the mechanism most likely to influence fertility.

In women with obesity, excess adipose tissue disrupts oestrogen and androgen balance, which in turn disrupts the hypothalamic-pituitary-ovarian axis and can suppress or irregularise ovulation. Reducing body weight (even by 5–10%) can restore more predictable cycles. Clinical trials in the SURMOUNT programme recorded average weight reductions well above that threshold at the higher doses, with some participants losing around 20% of body weight over 72 weeks. The full picture of how tirzepatide works helps explain why those results are meaningful beyond the scale.

For women with PCOS specifically, the picture is similar: insulin resistance drives androgen excess, which disrupts ovulation. Reducing that insulin resistance through weight loss may improve cycle regularity. None of this is a guarantee of pregnancy, and Mounjaro has not been studied as a fertility treatment. The NHS notes these medicines are not assessed for that purpose. What the evidence does support is that the weight-loss effect can change the hormonal environment, which is a different thing from a direct fertility action.

The contraception conversation you need to have before your next dose

This is the part of the Mounjaro-and-fertility question that catches people off guard. Because Mounjaro slows gastric emptying, it can reduce the absorption of oral medications taken at the same time, including the combined oral contraceptive pill. NHS England guidance is specific: women using oral contraceptives should add a barrier method (such as condoms) for the first four weeks of starting Mounjaro and for four weeks after every dose increase. The same guidance applies if you restart after a break.

The practical implication runs in both directions. If you want to avoid pregnancy during treatment, switching to or adding a non-oral method is important. If you are hoping to conceive, treatment should be stopped first, not paused. The MHRA advises a wash-out period before trying to conceive; your prescriber will tell you the appropriate length for your situation. Whether pregnancy during Mounjaro treatment carries risk is a related question with its own nuance, and it's worth reading before making any decisions.

The 12pm order cut-off matters far less here than getting this conversation right with a clinician before your plans change.

Stopping Mounjaro before trying to conceive, what 'not recommended' actually means

The SmPC for Mounjaro states it should not be used in pregnancy. Animal studies showed adverse developmental effects at doses used in reproductive toxicology testing, though translating animal data to human risk requires care. There is currently no substantial human safety dataset for tirzepatide use in pregnancy, which is precisely why the guidance is cautious: absence of evidence is not evidence of safety. The situation if you discover you are pregnant while taking Mounjaro has its own clinical pathway, and a prescriber or GP should be contacted promptly.

Stopping early (ideally before conception is attempted) is the standard clinical position. Weight regain may occur after stopping; this is a known pattern with GLP-1-class medicines and worth discussing with your prescriber so you can plan around it. Some women also find that fertility and weight after stopping Mounjaro raises questions about timing, and those are reasonable things to explore with a specialist.

The metabolic effects of tirzepatide, including improvements in liver function markers, are relevant background for women whose fertility difficulties are tied to metabolic conditions. That said, treatment decisions in a conception context should always involve a GP or reproductive specialist, not just a weight-loss service. Our clinical team can help direct you appropriately at consultation.

Who should be having this conversation, and when

If fertility is part of your thinking, the time to raise it is before starting Mounjaro, not after. A prescriber reviewing your consultation will want to know your plans. If you are already on treatment and your intentions have changed, contact your prescriber or GP, it is not a reason to stop suddenly without guidance, but it is a reason to act quickly.

Women with PCOS, endometriosis, or a history of irregular cycles should ideally involve a gynaecologist or reproductive endocrinologist in the conversation alongside any weight-management prescriber. Mounjaro can be one part of a broader picture; it is not a standalone fertility treatment and should never be framed as one.

If you're exploring treatment options for weight management and want to understand how a private, clinically supervised route works, a free consultation with our prescribers is the practical starting point. For any questions outside the consultation, our team is reachable through our support page. Speak to our prescribers and raise your fertility plans from the outset, it shapes everything that follows.